The recent data about the increasing proportion of splicing variants involved in genetic diseases 12, the absence of functional information for most BBS/ALMS1 variants and the previous studies reporting minigene assay as a good approach to evaluate splicing alterations 12, 17, 40 have encouraged us to conduct this study. The gene discussed is BBS2; the disease is hereditary disease.